Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C
CLINICAL AND EXPERIMENTAL NEPHROLOGY, cilt.17, sa.1, ss.115-119, 2013 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 17 Sayı: 1
- Basım Tarihi: 2013
- Doi Numarası: 10.1007/s10157-012-0663-x
- Dergi Adı: CLINICAL AND EXPERIMENTAL NEPHROLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.115-119
- Anahtar Kelimeler: Hepatitis C, Interferon, Hemodialysis patients
- Dokuz Eylül Üniversitesi Adresli: Hayır
Özet
Hepatitis C is the most frequently encountered hepatic disease in dialysis patients. Data related to pegylated interferon alfa-2a (Peg-IFN-alpha-2a) use in hemodialysis patients with hepatitis C virus (HCV) are limited. The aim of this study was to evaluate the efficacy of Peg-IFN-alpha-2a among these patients.